UnitedHealth’s Turnaround Gains Momentum: Buy, Sell, or Hold After the Q3 Beat?
UnitedHealth’s Turnaround Gains Momentum: Buy, Sell, or Hold After the Q3 Beat? NAI500
Covered in this story
Analyst targets on UnitedHealth Group
- Baird: $389 → $427 by Oct 2027 · Neutral via GuruFocus
- TD Cowen: $379 → $402 by Oct 2027 via GuruFocus
- Cantor Fitzgerald: $379 → $495 by Sep 2027 · Overweight via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $UNH yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on UnitedHealth Group →Dalsna Finance is currently tracking 52 stories mentioning UnitedHealth Group, the earliest published 22 Apr 2026.
Summary aggregated from NAI500's public RSS feed. The full reporting belongs to NAI500 — please read it on their site.